Prostate Cancer and supplementation
with alpha-tocopherol and beta-carotene:
incidence and mortality in a controlled trial
ABSTRACT:
BACKGROUND: Epidemiologic studies have
suggested that
vitamin E and beta-carotene may each influence the
development of prostate cancer. In the
Alpha-Tocopherol,
Beta-Carotene Cancer Prevention Study, a controlled trial, we studied the
effect of
alpha-tocopherol (a form of vitamin E) and
beta-carotene
supplementation, separately or together, on prostate cancer in male smokers.
METHODS: A total of 29,133 male smokers aged 50-69 years from southwestern Finland were randomly assigned to receive alpha-tocopherol (50mg), beta-carotene (20mg), both agents, or placebo daily for 5-8 years (median, 6.1 years). The supplementation effects were estimated by a proportional hazards model, and two- sided P values were calculated.
RESULTS: We found 246 new cases of and 62 deaths from prostate cancer during the follow-up period. A 32% decrease (95% confidence interval (CI)= -47% to 12%) in the incidence of prostate cancer was observed among the subjects receiving alpha-tocopherol (n=14564) compared with those not receiving alpha-tocopherol (n=14569). The reduction was evident in clinical prostate cancer but not in latent cancer. Mortality from prostate cancer was 41% lower (95% CI=-65% to 1%) among men receiving alpha-tocopherol. Among subjects receiving beta-carotene (n=14560), prostate cancer incidence was 23% higher (95% CI=30%-89%) compared with those not receiving beta-carotene. (n=14573). Neither agent had any effect on the time interval between diagnosis and death.
CONCLUSIONS: Long-term supplementation with alpha-tocopherol substantially reduced prostate cancer incidence and mortality in male smokers. Other controlled trials are required to confirm the findings.
Heinonen OP; Albanes D; Virtamo J; Taylor PR; Huttunen JK; Hartman AM; Haapakoski J;
Malila N; Rautalahti M; Ripatti S; Maenpaa H; Teerenhovi L; Koss L; Virolainen M’
Edwards BK. Department of Public Health, University of Helsinki, Finland. J Natl Cancer
Inst 1998 Mar 18;90(6):440-6. NLM CIT.ID:98180463. COMMENT: J Natl Cancer Inst 1998 Mar
18;90(6):414-5. J Natl Cancer Inst 1998 Mar 18;90(6):416-7.
Index of Articles
Click Here
Signup • Lost
Password • Edit Profile
for any specific ingredient, concern, vitamin, herb, etc...
• Health Club • Home •
Vitamins • Herbs • Minerals • Amino Acids • Enzymes • Hormones
Homeopathics • Ayurveda • Glandulars • Fatty Acids • Xtra-Cell
• Natural Medicines • Library • Physicians Only
Read The Latest Health Research • Prescription Drug Support Formulas Frozen Cellular Extracts • Xtra-Cell • Top Products •
Contact Us • Customer Service • Privacy Policy • Conditions Of Use
Pricing, Availability and Returns • Privacy Companies
Development Team
Nutrition Dynamics, Inc.• 510 West Court Street • Seguin, Texas 78155
800.926.2906
Copyright © 1998-2008 • All Rights Reserved • Patent Pending